{"id":"https://openalex.org/W2054716232","doi":"https://doi.org/10.1038/sj.bjc.6690774","title":"Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial","display_name":"Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial","publication_year":1999,"publication_date":"1999-10-15","ids":{"openalex":"https://openalex.org/W2054716232","doi":"https://doi.org/10.1038/sj.bjc.6690774","mag":"2054716232","pmid":"https://pubmed.ncbi.nlm.nih.gov/10555756","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2374290"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6690774","doi":"https://doi.org/10.1038/sj.bjc.6690774","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6690774","pdf_url":"https://www.nature.com/articles/6690774.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6690774.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073105004","display_name":"Maximiliano Van Kooten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125926","display_name":"Instituto Alexander Fleming","ror":"https://ror.org/02b0zvv74","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210125926"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"M Van Kooten","raw_affiliation_strings":["Alexander Fleming Institute, Buenos Aires, Argentina","Alexander Fleming Institute, Cramer 1180, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexander Fleming Institute, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210125926"]},{"raw_affiliation_string":"Alexander Fleming Institute, Cramer 1180, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210125926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077293060","display_name":"G. Traine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Traine","raw_affiliation_strings":["Hospital Israelita, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Israelita, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016168877","display_name":"Gabriela Cinat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Cinat","raw_affiliation_strings":["Instituto Angel H Roffo, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Angel H Roffo, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063256509","display_name":"Eduardo L. Cazap","orcid":"https://orcid.org/0000-0001-8632-6826","observed_orcids":["https://orcid.org/0000-0001-8632-6826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Cazap","raw_affiliation_strings":["Instituto Estevez, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Estevez, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030155674","display_name":"Alberto Zori Comba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Zori Comba","raw_affiliation_strings":["Hospital Zubizarrteta, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Zubizarrteta, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113147823","display_name":"H\u00e9ctor Vicente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405260759","display_name":"Hospital General de Agudos Dr. Enrique Torn\u00fa","ror":"https://ror.org/047rk3g12","country_code":"AR","type":"education","lineage":["https://openalex.org/I4405260759"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"H Vicente","raw_affiliation_strings":["Hospital Torn\u00fa, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Torn\u00fa, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4405260759"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079024021","display_name":"Susana Noemi Sena","orcid":"https://orcid.org/0000-0002-4511-6395","observed_orcids":["https://orcid.org/0000-0002-4511-6395"]},"institutions":[{"id":"https://openalex.org/I4210140850","display_name":"Hospital Alem\u00e1n","ror":"https://ror.org/03ydmxb41","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210140850"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"S Sena","raw_affiliation_strings":["Hospital Alem\u00e1n, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Alem\u00e1n, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210140850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041368612","display_name":"O Rodr\u00edguez Nievas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Rodriguez Nievas","raw_affiliation_strings":["Centro Oncologico de Excelencia, Gonnet, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Oncologico de Excelencia, Gonnet, Argentina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028033679","display_name":"Mauro Orlando","orcid":"https://orcid.org/0009-0003-5428-0394","observed_orcids":["https://orcid.org/0009-0003-5428-0394"]},"institutions":[{"id":"https://openalex.org/I4210125926","display_name":"Instituto Alexander Fleming","ror":"https://ror.org/02b0zvv74","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210125926"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"M Orlando","raw_affiliation_strings":["Alexander Fleming Institute, Cramer 1180, Buenos Aires, 1426, Argentina","Alexander Fleming Institute, Cramer 1180, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexander Fleming Institute, Cramer 1180, Buenos Aires, 1426, Argentina","institution_ids":["https://openalex.org/I4210125926"]},{"raw_affiliation_string":"Alexander Fleming Institute, Cramer 1180, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210125926"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":2.6219,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.89125088,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"81","issue":"5","first_page":"846","last_page":"849"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7773000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7773000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.21789999306201935,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.859000027179718},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/toxicity-profile","display_name":"toxicity profile","score":0.7250000238418579},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.9089999794960022},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7059999704360962},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6549999713897705},{"id":"https://openalex.org/keywords/platinum-refractory-disease","display_name":"platinum-refractory disease","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9164093732833862},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6487354040145874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6222822666168213},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5541460514068604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4810464680194855},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47257912158966064},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4393324553966522}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/sj.bjc.6690774","doi":"https://doi.org/10.1038/sj.bjc.6690774","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6690774","pdf_url":"https://www.nature.com/articles/6690774.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1507277","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2374290","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2374290","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2374290","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:10555756","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10555756","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.275.3409","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.275.3409","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/97/2b/Br_J_Cancer_1999_Nov_81(5)_846-849.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6690774","doi":"https://doi.org/10.1038/sj.bjc.6690774","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6690774","pdf_url":"https://www.nature.com/articles/6690774.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2054716232.pdf","grobid_xml":"https://content.openalex.org/works/W2054716232.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W65154174","https://openalex.org/W1857358013","https://openalex.org/W1858072261","https://openalex.org/W1922104747","https://openalex.org/W1938837918","https://openalex.org/W1963786241","https://openalex.org/W2001996041","https://openalex.org/W2086370927","https://openalex.org/W2092569103","https://openalex.org/W2094449527","https://openalex.org/W2104225601","https://openalex.org/W2118512375","https://openalex.org/W2135352785","https://openalex.org/W2255819252","https://openalex.org/W2262092684","https://openalex.org/W2461906409","https://openalex.org/W4239714259"],"related_works":["https://openalex.org/W2171560504","https://openalex.org/W7098750144","https://openalex.org/W2124597836","https://openalex.org/W2181570036","https://openalex.org/W2021966701","https://openalex.org/W2001996041","https://openalex.org/W1975262381","https://openalex.org/W175941782","https://openalex.org/W2144583214","https://openalex.org/W1911047310"],"abstract_inverted_index":{"The":[0],"activity":[1,245],"and":[2,35,86,103,126,136,176,190,218,239,246],"mild":[3,201],"toxicity":[4,36],"profile":[5,37],"of":[6,38,50,77,105,118,149,174,248],"single-agent":[7,39,249],"gemcitabine":[8,40,94,250],"therapy":[9,175],"in":[10,41,144,215,222,251],"untreated":[11],"(chemonaive)":[12],"patients":[13,43,121,138,167,179,253],"with":[14,44,47,232,254],"non-small-cell":[15],"lung":[16],"cancer":[17],"(NSCLC)":[18],"is":[19],"well":[20],"documented.":[21],"This":[22,241],"phase":[23],"II":[24],"trial":[25],"was":[26,159,187,195,199],"conducted":[27],"to":[28,262],"determine":[29],"the":[30,244],"objective":[31],"tumour":[32],"response":[33,135,142,147,157],"rate":[34,148],"pretreated":[42,252],"NSCLC.":[45],"Patients":[46],"histological":[48],"evidence":[49],"advanced":[51,255],"NCSLC":[52],"stage":[53],"IIIB":[54],"or":[55,66,207,260],"IV;":[56],"at":[57],"least":[58],"one":[59,216,229],"prior":[60],"chemotherapy":[61],"regimen":[62],"including":[63],"a":[64,106,133,140,145],"platinum":[65],"taxane":[67],"analogue;":[68],"an":[69],"Eastern":[70],"Cooperative":[71],"Oncology":[72],"Group":[73],"(ECOG)":[74],"performance":[75],"status":[76],"0-2;":[78],"clinically":[79],"measurable":[80],"disease;":[81],"adequate":[82,87],"bone":[83],"marrow":[84],"reserve;":[85],"renal":[88],"function;":[89],"received":[90],"1000":[91],"mg":[92],"m(-2)":[93],"administered":[95],"over":[96],"30":[97],"min":[98],"on":[99],"days":[100],"1,":[101],"8":[102],"15":[104],"28-day":[107],"cycle":[108],"defined":[109],"as":[110],"3":[111,188,206,213,220,234],"weekly":[112],"treatments":[113],"followed":[114],"by":[115],"1":[116],"week":[117],"rest.":[119],"Twenty-nine":[120],"were":[122],"evaluated":[123],"for":[124,128],"efficacy":[125],"32":[127],"toxicity.":[129],"One":[130],"patient":[131,217,230],"achieved":[132],"complete":[134],"five":[137],"had":[139,180],"partial":[141],"resulting":[143],"total":[146],"20.6%":[150],"(95%":[151],"confidence":[152],"interval":[153],"(CI)":[154],"6-34).":[155],"Median":[156,183],"duration":[158],"7":[160],"months":[161,189],"(range":[162],"4-11":[163],"months).":[164],"Twelve":[165],"(41%)":[166],"reached":[168],"stable":[169],"disease":[170,181],"after":[171],"two":[172,223],"cycles":[173],"11":[177],"(38%)":[178],"progression.":[182],"progression-free":[184],"survival":[185,193],"time":[186,194],"median":[191],"overall":[192],"5.5":[196],"months.":[197],"Toxicity":[198],"generally":[200],"(grades":[202],"0-2).":[203],"Severe":[204,225],"(grade":[205],"4)":[208],"haematological":[209],"toxicities":[210,227],"included":[211,228],"grade":[212,219,233],"anaemia":[214],"thrombocytopenia":[221],"patients.":[224],"non-haematological":[226],"each":[231],"liver":[235],"transaminase":[236],"elevations,":[237],"nausea/vomiting":[238],"diarrhoea.":[240],"study":[242],"confirms":[243],"safety":[247],"NSCLC":[256],"who":[257],"are":[258],"refractory":[259],"sensitive":[261],"first-line":[263],"therapy.":[264]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}